Stock listing

CGEM Stock Price, News, Filings & Events — Cullinan Therapeutics, Inc.

Selected listing: CGEM · NASDAQ · USD · US

This page tracks Cullinan Therapeutics, Inc.'s CGEM:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGEM:NASDAQ. CGEM:NASDAQ is the stock-level entry point for investors researching Cullinan Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cullinan Therapeutics, Inc. (CGEM) is a public company based in the United States, focusing on innovative cancer therapies. With a market capitalization of approximately $1.09 billion, Cullinan is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company is committed to addressing unmet medical needs in oncology through its research and development efforts.